Heartware Intl Inc (HWIFF) 2.0000 $HWIFF HeartWare

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Heartware Intl Inc (HWIFF) 2.0000 $HWIFF

HeartWare Receives FDA Approval To Enroll Supplemental Patient Cohort In Destination Therapy Trial
PR Newswire - Tue Aug 27, 8:10AM CDT
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to commence enrollment in an additional patient cohort for ENDURANCE, the Company's pivotal, Destination Therapy clinical study.

Investment Initiatives, Financial Results, Investor Conferences, Dividends, and FDA Approvals - Research Report on CareFusion, Teleflex, Cooper, HeartWare, and Thoratec
PR Newswire - Thu Aug 15, 7:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.

HeartWare Presentation At The Canaccord Genuity 2013 Annual Growth Conference To Be Webcast
PR Newswire - Fri Aug 09, 3:00PM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 2013 Annual Growth Conference at 3:00 p.m. EDT on Wednesday, August 14, 2013. The conference is being held August 14-15 at the The InterContinental Boston.

HeartWare International Reports $50.8 Million In Second Quarter 2013 Revenue; 75% Increase From Second Quarter Of 2012
PR Newswire - Thu Aug 08, 6:00AM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $50.8 million for the second quarter ended June 30, 2013, a 75% increase compared to $29.1 million in revenue for the same period of 2012.

HeartWare Schedules Second Quarter Conference Call And Webcast
PR Newswire - Fri Jul 19, 5:00AM CDT
HeartWare International, Inc. (NASDAQ:HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three months ended June 30, 2013, at 8:00 a.m. U.S. Eastern Daylight Time on Thursday, August 8, 2013. The Company plans to release the financial results prior to the conference call.

Leadership Changes, New Studies, Acquisitions, New Care Facilities, and Business Transformations - Research Report on Cigna, HeartWare, Acadia, Magellan, and Haemonetics
PR Newswire - Tue Jun 25, 7:00AM CDT
Today, Wall Street Reports announced new research reports highlighting CIGNA Corporation (NYSE: CI), HeartWare International Inc. (NASDAQ: HTWR), Acadia Healthcare Company Inc. (NASDAQ: ACHC), Magellan Health Services Inc. (NASDAQ: MGLN), and Haemonetics Corporation (NYSE: HAE). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
PR Newswire - Mon Jun 17, 7:50AM CDT
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to an IDE (Investigational Device Exemption) Supplement that allows HeartWare to commence enrollment in an additional patient cohort for ENDURANCE, the Company's pivotal, Destination Therapy clinical study.

HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
PR Newswire - Thu Jun 13, 8:00AM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference at 9:25 a.m. EDT on Tuesday, June 18, 2013. The conference is being held June 18-19 at the The InterContinental Boston.

HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
PR Newswire - Wed Jun 12, 7:00AM CDT
HeartWare International, Inc. (NASDAQ:HTWR - ASX:HIN), today announced that it has requested and received approval from ASX Limited for its removal from the official list of ASX. Trading in HeartWare's CHESS Depositary Interests (CDIs) will be suspended on ASX at the close of market on September 10, 2013.

HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
PR Newswire - Tue Jun 04, 11:20AM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Goldman Sachs 34th Annual Global Healthcare Conference at 8:00 a.m. PDT (11:00 am EDT) on Wednesday, June 12, 2013. The conference is being held June 11-13 at the Terranea Resort in Rancho Palos Verdes, CA.

HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
PR Newswire - Thu May 16, 3:00PM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, May 20, 2013. The conference is being held May 20-22, 2013 at the Sheraton New York Hotel.

HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
PR Newswire - Fri May 10, 12:59PM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2013 Health Care Conference at 8:00 a.m. PDT (11:00 am EDT) on Thursday, May 16, 2013. The conference is being held May 14-16, 2013 at the Encore at Wynn in Las Vegas.

HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
PR Newswire - Mon Apr 29, 3:10PM CDT
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $49.2 million for the first quarter ended March 31, 2013, an 87% increase compared to $26.4 million in revenue for the same period of 2012.

HeartWare Schedules First Quarter Conference Call And Webcast
PR Newswire - Mon Apr 15, 5:00AM CDT
HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three months ended March 31, 2013, at 5:00 p.m. U.S. Eastern Daylight Time on Monday, April 29, 2013. The Company plans to release the financial results prior to the conference call.

HeartWare International, Inc. Announces Closing of Public Offering of Common Stock
PR Newswire - Mon Mar 18, 11:21AM CDT
HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) ("HeartWare") announced today the completion of a public offering of 1,725,000 shares of common stock, at a price per share of $86.45 pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") on December 9, 2010. This amount includes 225,000 additional shares of common stock sold pursuant to the underwriters' exercise in full of their option to purchase additional shares of common stock to cover over-allotments.

HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
PR Newswire - Tue Mar 12, 7:41PM CDT
HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) ("HeartWare") announced today the pricing of a public offering of 1,500,000 shares of common stock at a price per share of $86.45 pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). HeartWare also granted the underwriters an option to purchase up to an additional 225,000 shares to cover over-allotments, if any.

HeartWare International, Inc. Announces Public Offering of Common Stock
PR Newswire - Mon Mar 11, 3:00PM CDT
HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) ("HeartWare") announced today its intention to offer, subject to market and other conditions, 1,500,000 shares of common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). HeartWare also intends to grant the underwriters an option to purchase up to an additional 225,000 shares to cover over-allotments, if any.

Leveraging Results to Drive New Innovation - Research Report on Medtronic, Inc., Edwards Lifesciences, Cyberonics, Inc., HeartWare International and Luxottica Group SpA
PR Newswire - Thu Mar 07, 7:00AM CST
Today, Investors Alliance announced new research reports highlighting Medtronic, Inc. (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW), Cyberonics, Inc. (NASDAQ:CYBX), HeartWare International Inc (NASDAQ:HTWR) and Luxottica Group SpA (NYSE:LUX). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
PR Newswire - Wed Mar 06, 8:00AM CST
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Barclays Capital 2013 Global Healthcare Conference at 11:15 a.m. EDT on Tuesday, March 12, 2013. The conference is being held March 12-14, 2013 at the Loews Miami Hotel, Florida.

HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
PR Newswire - Thu Feb 28, 9:47AM CST
HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 34th Annual Institutional Investors Conference at 1:05 p.m. Eastern Standard Time on Tuesday, March 5, 2013. The conference is being held March 3-6 at the JW Marriott Grande Lakes in Orlando.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 27

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 33

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 278

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 14

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 147

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 202

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 86

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 16

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 114

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 80

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading

Top 5 Most Recently Viewed Articles

Sotelix Endoscopy Secures $1.7 Million to Innovate Gastro Care

Updated Category News Views 167

Sotelix Endoscopy Secures $1.7 Million in Seed Funding Sotelix Endoscopy, a forward-thinking medical device startup, has recently completed a successful seed round financing, raising an impressive $1.7 million. With this funding, the company will accelerate its research and development of next-generation therapeutic endoscopy devices, which are designed to significantly...

Continue Reading
TriplePoint Venture Growth BDC Faces Market Turbulence

Updated Category News Views 68

Challenges Faced by TriplePoint Venture Growth BDC Corp. In today's ever-shifting market landscape, TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) stock has recently reached a troubling 52-week low, settling at $6.59. This dramatic downturn is the result of investor caution, mirroring a significant 1-year shift of -31.5% in the company's valuation. Specializing in...

Continue Reading
Dave Aronberg Launches New Law Firm, Aims to Make an Impact

Updated Category News Views 349

Dave Aronberg Launches New Law Firm In an exciting new chapter, Dave Aronberg, a well-respected figure in the legal realm, has taken a significant step forward by establishing his own law firm. Having dedicated over two decades as a public servant, Aronberg will now lead a boutique firm specializing in both civil and criminal litigation, as well as land use planning. New...

Continue Reading
2026 Agricultural Outlook: A Dramatic Shift in Farmer Sentiment

Updated Category News Views 163

Shifting Emotions in Agriculture: January 2026 Overview Farmer sentiment has fallen significantly as we step into 2026, reflecting increasing economic anxieties. The recent Ag Economy Barometer, a vital measure of agricultural optimism, showed a considerable drop of 23 points from December to a reading of 113. This downturn points to a growing sense of disillusionment...

Continue Reading
Mattamy Homes Launches Exciting New Community in Goodyear

Updated Category News Views 339

Mattamy Homes Unveils New Community in Goodyear Mattamy Homes proudly announces the grand opening of its latest community, Las Ventanas, in one of the fastest-growing suburban areas. This exciting development offers 18 innovative and unique floor plans designed to meet the needs of modern families. Discover the Las Ventanas Community Las Ventanas represents the commitment...

Continue Reading